Skip to main content
Clinical Trials/NCT01307748
NCT01307748
Completed
Phase 2

Physiologic and Expectancy Effects of Stress-reducing Aroma in Older Adults

Oregon Health and Science University1 site in 1 country92 target enrollmentDecember 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Stress-related Problems
Sponsor
Oregon Health and Science University
Enrollment
92
Locations
1
Primary Endpoint
Percent of Baseline Level of Salivary Cortisol
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The study purpose is to evaluate efficacy of stress-reducing aromatherapy and learn about how aromatherapy works.

Detailed Description

The study purpose is to evaluate efficacy of stress-reducing aromatherapy and learn about how aromatherapy works by comparing participants' physiologic responses to laboratory challenge tasks with and without experiencing aromatherapy.

Registry
clinicaltrials.gov
Start Date
December 2010
End Date
December 2012
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Barry S. Oken

Professor

Oregon Health and Science University

Eligibility Criteria

Inclusion Criteria

  • in good physical and cognitive health
  • reporting moderate level of stress
  • able to perceive aromas
  • able to understand and follow study instructions

Exclusion Criteria

  • taking medications affecting central nervous system (CNS) function or physiologic measures (e.g. steroids or neuroleptics)
  • reporting smell sensitivities or allergies
  • smoking presently or in the past less than one year prior to enrollment

Outcomes

Primary Outcomes

Percent of Baseline Level of Salivary Cortisol

Time Frame: assessed at baseline (60 min prior to aroma exposure and stress), stress battery (30 min after aroma exposure and during stress), post-stress (60 min after completing stress battery)

Percent of baseline level of salivary cortisol (values greater than baseline indicate increased stress)

Secondary Outcomes

  • Cognitive Performance: Percent Change From Baseline in Digit Span Backward Task Score(Baseline (60 min prior to aroma exposure and stress), post-stress (60 min after completing stress battery))
  • Electroencephalography (EEG) Frontal Asymmetry(assessed at baseline (60 min prior to aroma exposure and stress), at the onset of aromatherapy exposure, stress battery (30 min after aroma exposure and during stress), post-stress (60 min after completing stress battery))

Study Sites (1)

Loading locations...

Similar Trials